ArcScan
ArcScan develops the Insight 100, a computer-controlled 50 MHz robotic very-high-frequency ultrasound device for ophthalmic anterior-segment imaging behind the iris, serving refractive surgeons, ophthalmology clinics, and military/government eye-care facilities across approximately 70 installed sites worldwide.
- Company typePrivate
- Founded2007
- HeadquartersGolden, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ArcScan does
ArcScan, Inc. is a private medical technology company founded in 2007 and headquartered in Golden, Colorado, that develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system for ophthalmic anterior-segment diagnostics. The device's core technology, the proprietary Swept Beam Liquid Interface originally developed at Columbia/Weill University and exclusively licensed to ArcScan, uses a mechanically scanned transducer to image anatomy behind the iris — the so-called "Dark Zone" — that optical modalities such as OCT cannot penetrate, with epithelial mapping accuracy down to 1 micron. Clinical applications include pIOL/ICL sizing for refractive surgery, keratoconus screening, corneal/refractive assessment, glaucoma evaluation (including angle, ciliary body, and MIGS planning), and cataract/IOL planning. The platform comprises the Insight 100 hardware (instrument module, fluidics module, electronics), the Insight software package with DICOM/PACS integration and pre-configured clinical scan sets, and the EyeSeal single-patient sterile disposable interface.
The company sells through a sales-led motion with regional sales managers and a VP of Sales and Marketing engaging ophthalmology clinics, refractive surgery centers, academic institutions, and military hospitals directly, supplemented by industry-conference presence (notably AAO) and channel partners — Lovell Government Services for the US military and Shanghai Haohai Biological Technology together with Hangzhou Aijinglun Technology for China following NMPA approval in May 2024. Revenue is generated through capital-equipment sales of the Insight 100, recurring per-procedure sales of EyeSeal disposables (ordered via a Salesforce-based portal), and bundled clinical training. The company holds 19 patents (with up to 26 issued and pending across sources), has cleared FDA 510(k) and CE mark, and reports an installed base of approximately 70 clinics worldwide.
ArcScan's strategic posture is anchored by a deeply clinical leadership team and board: founder/CMO Dr. Dan Reinstein (London Vision Clinic), chairman Dr. Zhaoxing Dai (Shanghai Meishi Ophthalmic & Optics Research Institute), board director Dr. Robert Lin (IQ Laser Vision, 70,000+ refractive procedures), and CEO J. Erik Giphart, Ph.D. (promoted from VP of Engineering in July 2024). The single disclosed institutional capital event is an $11.15 million Preferred Series B from Shanghai Haohai Biological Technology Ltd. in July 2021, which seeded the China expansion that culminated in NMPA clearance and a China-focused go-to-market structure.
ArcScan firmographics
Firmographics- Name
- ArcScan
- Legal name
- ArcScan, Inc.
- Website
- https://arcscan.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ArcScan develops the Insight 100, a computer-controlled 50 MHz robotic very-high-frequency ultrasound device for ophthalmic anterior-segment imaging behind the iris, serving refractive surgeons, ophthalmology clinics, and military/government eye-care facilities across approximately 70 installed sites worldwide.
- Ownership category
- akta.pro rank
Where ArcScan is headquartered
LocationHeadquarters
- HQ city
- Golden
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ArcScan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Insight 100 Device Sales: Sale of the Insight 100 ophthalmic ultrasound imaging device to clinics, hospitals, and academic institutions. The device is a capital equipment purchase requiring in-person sales engagement and installation.
- EyeSeal Disposable Consumables: Recurring revenue from sterile, single-patient disposable EyeSeal interfaces used during each scan procedure. Consumables are ordered per-patient through the ordering system.
- Clinical Services and Training: Pre-training materials, in-person didactic and hands-on training included with device purchase. Ongoing clinical applications support available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Insight 100 Device - Quote-based pricing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
ArcScan product offering
Product offeringCore offering
ArcScan develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system that captures precise, repeatable images of the anterior segment of the eye, including anatomy behind the iris that optical technologies (e.g., OCT) cannot visualize. The platform consists of the Insight 100 hardware (instrument module, fluidics module, electronics unit), the EyeSeal single-patient disposable interface, and the Insight software package, sold as capital equipment to ophthalmology clinics for ICL/pIOL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma evaluation, and cataract/IOL planning.
Product overview
ArcScan offers the Insight 100 Platform as a unified ophthalmic imaging system consisting of the Insight 100 hardware device (with robotic probe, fluidics module, and electronics unit), the EyeSeal Disposable (sterile single-patient consumable), and the Insight Software Package. The platform uses very-high-frequency ultrasound technology to image areas of the eye behind the iris that optical technologies cannot penetrate, serving clinical applications including pIOL/ICL sizing, corneal tomography, keratoconus screening, glaucoma management, and cataract IOL planning. The system is installed in approximately 70 clinics worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Insight 100: The next-generation evolution of the Artemis is a more comfortable, repeatable system for capitalizing on the ability of ultrasound to capture anatomy behind the iris. The Insight 100 is a computer-controlled high-frequency ultrasound device designed to equip ophthalmologists with precise, detailed images of the entire anterior segment of the eye.
- EyeSeal
- Swept Beam Liquid Interface
Products and services
- Insight 100 Platform Computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging device for ophthalmologists and refractive surgeons, providing precise, repeatable imaging of the entire anterior segment of the eye including areas behind the iris. Comprises the ArcScan instrument module, fluidics module, electronics unit, and Insight software. Used for pIOL/ICL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma management, and cataract/IOL planning.
- EyeSeal Disposable Sterile, single-patient-use disposable interface designed like a swim goggle and filled with saline solution. Creates a sealed fluid pathway between the patient and the Insight 100 transducer so the transducer never contacts the patient's eye, preventing cross-contamination between patients. Ordered per procedure through ArcScan's Salesforce ordering portal.
Quantifiable outcome
- Epithelial mapping accuracy down to 1 micron
- +4 more outcomes
Companies that use ArcScan
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles3 records
ArcScan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature8 records
ArcScan partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and regional.
- Dr. Robert Lin / IQ Laser VisioncoreDr. Robert Lin, Founder and CEO of IQ Laser Vision (70,000+ refractive procedures over 25 years), joined ArcScan's Board of Directors in June 2023. His practice utilizes three Insight 100 devices and serves as lead clinical reference. International trainer for SMILE (Zeiss) and EVO ICL (Staar). Brings US and China market expertise to fuel ArcScan's marketplace momentum.
- Lovell Government ServicescoreExclusive US partner for military ordering of ArcScan products including Insight 100 and EyeSeal consumables. Handles all government contracting for military customers. Contact: lovellgovt@ Gottlieb & [email protected] or 850.684.1867.
- Hangzhou Aijinglun Technology Co., Ltd.regionalCEO Ying (Harvey) Hou oversees promotion and sales of Insight 100 device in China market as well as advancement of the device's Chinese version. Core responsibilities include R&D, manufacturing, and sales of posterior chamber phakic refractive lenses combined with Insight 100 imaging solutions.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
ArcScan competitors and assessment
Company assessmentDirect peers
- Sonomed Escalon: Sonomed Escalon manufactures ultrasound biomicroscopy (UBM) devices for ophthalmic anterior segment imaging — directly competing with ArcScan's Insight 100 in the same clinical use cases including glaucoma and IOL sizing. Their VuMax and other UBM systems are the incumbent ultrasound alternative that ArcScan displaces.
- Quantel Medical: Quantel Medical (Lumibird Medical division) produces ophthalmic ultrasound platforms including UBM and B-scan devices for anterior and posterior segment imaging. They compete head-to-head with ArcScan in ICL sizing and glaucoma evaluation use cases.
Broad incumbents
- Carl Zeiss Meditec: Carl Zeiss Meditec is a dominant incumbent in ophthalmic diagnostics with its IOLMaster optical biometry and Cirrus OCT platforms. While not focused on VHF ultrasound, its IOLMaster is the standard for IOL power calculations, making it the primary non-ultrasound alternative for refractive surgical planning.
- Heidelberg Engineering: Heidelberg Engineering manufactures the ANTERION anterior segment OCT and SPECTRALIS imaging platforms, widely used for refractive surgery planning and glaucoma assessment. Their OCT-based approach is the primary optical alternative to ArcScan's ultrasound imaging.
- Nidek: Nidek offers a broad portfolio of ophthalmic diagnostic devices including optical biometry (AL-Scan), refractors, and ultrasound A-scan systems used in refractive surgery workflows. They compete in the same clinical applications as ArcScan across multiple geographies.
- Topcon Healthcare: Topcon Healthcare produces OCT, fundus imaging, and biometry systems (including the Aladdin) used in ophthalmic diagnostics and refractive surgery planning. They are a broad incumbent offering overlapping capabilities to ArcScan's anterior segment imaging platform.
- Tomey Corporation: Tomey Corporation manufactures ophthalmic diagnostic equipment including optical biometry (OA-2000), specular microscopy, and ultrasound devices. Their multi-modality offerings compete in the same refractive surgery and anterior segment imaging workflow as ArcScan.
- Haag-Streit Group: Haag-Streit offers ophthalmic imaging and biometry solutions (including the Lenstar optical biometer) widely used in cataract and refractive surgery clinics. They represent an incumbent alternative in the surgical planning workflow where ArcScan's Insight 100 is positioned.
Emerging players
- Icare (Revenio Group): Icare specializes in ophthalmic diagnostic devices with a primary focus on tonometry (glaucoma screening), and has expanded into broader imaging. Their iCare product line competes in the ophthalmic point-of-care diagnostic space adjacent to ArcScan's clinical applications.
- STAAR Surgical: STAAR Surgical manufactures the EVO ICL (Implantable Collamer Lens) — the phakic IOL product whose implantation workflow drives much of ArcScan's ICL sizing demand. While not a direct imaging competitor, STAAR's commercial success directly impacts ArcScan's addressable procedure volumes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
ArcScan social profiles
Digital presenceArcScan compliance and trust
Trust signalCompliance3 records
ArcScan financial estimates
Financial estimateRevenue estimate
Valuation estimate
ArcScan leadership team
Management profileNumber of profiles
Profiles7 records
ArcScan funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ArcScan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ArcScan
What does ArcScan do?
ArcScan develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system that captures precise, repeatable images of the anterior segment of the eye, including anatomy behind the iris that optical technologies (e.g., OCT) cannot visualize. The platform consists of the Insight 100 hardware (instrument module, fluidics module, electronics unit), the EyeSeal single-patient disposable interface, and the Insight software package, sold as capital equipment to ophthalmology clinics for ICL/pIOL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma evaluation, and cataract/IOL planning.
Is ArcScan a public or private company?
ArcScan is a private company. It is classified as venture growth investor backed and is currently operating.
When was ArcScan founded?
ArcScan was founded in 2007. It employs 11 to 50 people.
Where is ArcScan based?
ArcScan is headquartered in Golden, United States, in the North America region.
How does ArcScan make money?
Three revenue lines are on record. Insight 100 Device Sales are the primary driver. The others are eyeSeal Disposable Consumables and clinical Services and Training.
Who are ArcScan's main competitors?
Direct peers on record are Sonomed Escalon and Quantel Medical. Broad incumbents are Carl Zeiss Meditec, Heidelberg Engineering, Nidek, Topcon Healthcare, Tomey Corporation and Haag-Streit Group. Emerging players are Icare (Revenio Group) and STAAR Surgical.
Does ArcScan have an API?
No public API is recorded for ArcScan.